US Is Home to More Than 18 Million Cancer Survivors
There were more than 18 million cancer survivors in the United States at the beginning of this year, according to new data.
Lung Cancer
Factors Associated With Non-Small Cell Lung Cancer Stage at Presentation
Researchers identified demographic and socioeconomic factors associated with differences in staging of non-small cell lung cancer at initial presentation.
Rate of CRT-Related Pneumonitis in NSCLC May Be Higher in Real World Than in Clinical Trials
The pooled incidence of chemoradiation-induced grade 3-5 pneumonitis was 3.62% in randomized trials, 5.98% in observational studies, and 7.85% in observational studies of platinum doublet chemotherapy.
More African Americans Screened for Lung Cancer With USPSTF 2021 Criteria
African-American patients were more likely to be eligible for lung cancer screening using USPSTF’s 2021 criteria vs 2013 criteria.
Income, Education Linked to Advanced Stage of Diagnosis of NSCLC
Findings persist across racial/ethnic groups, regardless of government or private insurance, and across facility types.
LDCT Screening Tied to Lower Incidence of Advanced Lung Cancer
The incidence of advanced lung cancer declined by 3 cases per 100,000 people per year in 2015-2018 relative to 2004-2014.
Increased Stage I Lung Cancer Diagnoses Driven by NSCLC
The percentage of patients with stage I disease increased from 23.5% in 2010 to 29.1% in 2017.
Amivantamab-Lazertinib Active in EGFR-Mutant NSCLC After Exhausting Standard Care Options
The overall response rate was 33%, with 1% of patients having complete responses and 32% having partial responses.
Eftilagimod Alpha, Pembrolizumab Combo Encouraging in PD-L1-Unselected NSCLC
TACTI-002, enrolled 114 patients with untreated locally advanced or metastatic non-small cell lung cancer, unselected for PD-L1 expression.
Adagrasib Promising in KRASG12C-Mutated NSCLC
The researchers noted that responses were deep, with 75% of responders achieving a greater than 50% tumor reduction.
- Loading...
Loading...
Next post in ASCO 2022 Lung Cancer In-Depth
Loading... 
Loading...